Sandwalk BioVentures and CosmosID Launch Joint GRAS Genomic Reporting Service

Sandwalk BioVentures and CosmosID Launch Joint GRAS Genomic Reporting Service
News provided by
Share this article
Share this article
MADRID, Spain and ROCKVILLE, Md., June 3, 2021 /PRNewswire/ -- Sandwalk BioVentures and CosmosID today announced the launch of a new joint service offering for Generally-Recognized As Safe (GRAS) regulatory genomic reporting for the Probiotics market in the USA. By combining CosmosID's end-to-end microbial genomics infrastructure with Sandwalk's regulatory experience and expertise, developers of the next generation of probiotics will now have access to an optimized service offering. Through compliant sequencing, analysis and reporting, the two companies aim to support the probiotics market in fostering the next generation of functional bacterial strains.

Related Keywords

United States ,Spain ,Madrid ,Luis Gosalbez ,Prnewswire Sandwalk Bioventures ,Sandwalk Bioventures ,Manoj Dadlani ,Christian Roghi ,Generally Recognized As Safe ,Genomic Reporting ,Managing Director ,Strategic Alliances ,Genomic Sequencing ,Reporting Bundle ,Next Generation Sequencing ,Cosmosid ,ஒன்றுபட்டது மாநிலங்களில் ,ஸ்பெயின் ,மாட்ரிட் ,மனோஜ் தத்லானி ,நிர்வகித்தல் இயக்குனர் ,மூலோபாய கூட்டணிகள் ,அடுத்தது ஜெநரேஶந் வரிசைப்படுத்துதல் ,